Subscribe To
Moderna and merck reveal new data on individualized cancer treatment
Moderna MRNA, +1.55% and Merck & Co. MRK, +1.43% on Monday released new results from a trial evaluating Moderna's mRNA-based ...
June 5, 2023, 9:19 am
Day one biopharmaceuticals shares jump 23% on positive results for glioma treatment
Day One Biopharmaceuticals DAWN, -0.37% shares climbed 23% in premarket trading Monday after the company shared new data on tovorafenib, an ...
June 5, 2023, 8:09 am
Elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
Elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
Elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
Elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
Elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
Sanofi (sny) nextgen multiple sclerosis drug meets phase ii goal
Sanofi's (SNY) phase II study on its novel investigational anti-CD40L antibody, frexalimab, meets the p...
May 31, 2023, 1:16 pm
Numinus wellness announces largest-of-its-kind study of psilocybin therapy to treat depression
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) said its wholly-owned subsidiary Cedar Clinical Research (CCR) has begun studying COMP360 psilocybin ther...
May 30, 2023, 8:33 am
Dyne therapeutics: force platform poised to revolutionize gene therapy
Dyne Therapeutics, Inc. has announced that its investigational therapeutic, DYNE-251, for Duchenne musc...
May 27, 2023, 10:02 pm
Roche to present new data in blood cancers and solid tumours from its broad portfolio at asco 2023
Basel, 26 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will be presenting new data on six approved and invest...
May 26, 2023, 1:00 am
Theratechnologies to present preliminary safety and efficacy data from phase 1 trial of sudocetaxel zendusortide in heavily pretreated cancer patients at asco 2023
MONTREAL, May 25, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharma...
May 25, 2023, 5:31 pm
Celularity announces $45 million purchase order, first middle east private label agreement for celularity’s halal-certified biomaterial products
Builds on Celularity’s December 2022 announcement of Halal Certification of its commercial-stage biomaterial products, and clinical and ...
May 23, 2023, 12:10 pm
Why pfizer stock crushed the market on monday
A medical journal detailed some very encouraging results of a diabetes and weight-loss investigational ...
May 22, 2023, 5:31 pm
Moderna (mrna) posts upbeat data on protein replacement therapy
Interim data from a study shows that Moderna's (MRNA) investigational therapy for propionic acidemia (P...
May 22, 2023, 12:50 pm
Why is avrobio (avro) stock up 83% today?
AVROBIO (NASDAQ: AVRO ) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NYSE: NVS ). This deal has...
May 22, 2023, 11:43 am
Immunovant provides corporate updates and reports financial results for the fourth quarter and fiscal year ended march 31, 2023
investigational New Drug (IND) application and Clinical Trial Application (CTA) for IMVT-1402 cleared b...
May 22, 2023, 11:00 am
Dupixent® (dupilumab) late-breaking phase 3 copd results presented at ats and simultaneously published in the new england journal of medicine
Dupixent is the first and only investigational biologic for COPD that has demonstrated a significant re...
May 21, 2023, 6:18 pm
Apnimed presented positive phase 2b results on ad109, an investigational oral drug for obstructive sleep apnea, for the first time at ats 2023
— New MARIPOSA Study Data Showed AD109 Statistically Significantly Improved Both Objective and Subjective Outcomes in OSA Patients — MARIPOSA Resu...
May 21, 2023, 2:00 pm
Roche's (rhhby) ms drug meets goals in the phase ii study
Roche's (RHHBY) investigational oral fenebrutinib meets its primary and secondary endpoints in the phas...
May 17, 2023, 12:47 pm